MAPT and Alzheimer disease: Relatedly, the loss of poly(A) deadenylase parn-2/TOE1 leads to increased tau pathology in C. elegans and correlates with MSUT2 expression and increased tau pathology in AD patient brains (Kow et al. 2021).